Raffaella Buzzetti

Pubblicazioni

Titolo Pubblicato in Anno
IFN-α neutralizing antibodies distinguish LADA from early-onset type 1 diabetes THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 2025
Residual C-peptide secretion is associated with better CGM-metrics in adults with short-lasting type 1 diabetes DIABETES RESEARCH AND CLINICAL PRACTICE 2025
Cardiac autonomic neuropathy is associated with ectopic fat distribution in autoimmune but not in type 2 diabetes CARDIOVASCULAR DIABETOLOGY 2025
Searching the Crystal Ball for Tailored GLP‐1 Receptor Agonists Treatment in Type 2 Diabetes and Obesity DIABETES/METABOLISM RESEARCH AND REVIEWS 2025
Saxagliptin/dapagliflozin is non‐inferior to insulin glargine in terms of β‐cell function in subjects with latent autoimmune diabetes in adults: A 12‐month, randomized, comparator‐controlled pilot study DIABETES, OBESITY AND METABOLISM 2024
Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk THE LANCET REGIONAL HEALTH. EUROPE 2024
IDegLira for the real-world treatment of type 2 diabetes in Italy. Final results from the REX observational study DIABETES, OBESITY AND METABOLISM 2024
Immune checkpoint modulators in early clinical development for the treatment of type 1 diabetes EXPERT OPINION ON INVESTIGATIONAL DRUGS 2024
Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk THE LANCET REGIONAL HEALTH. EUROPE 2024
LADA 30th anniversary: A growing form of diabetes with persistent unresolved questions DIABETES/METABOLISM RESEARCH AND REVIEWS 2024
No differences in kidney function decline between people with type 2 diabetes starting a sodium-glucose cotransporter 2 inhibitor or a glucagon-like peptide-1 receptor agonist: a real-world retrospective comparative observational study CLINICAL THERAPEUTICS 2024
Open questions on basal insulin therapy in T2D: a Delphi consensus ACTA DIABETOLOGICA 2024
Improved HbA1c and body weight in GADA-positive individuals treated with tirzepatide: A post hoc analysis of SURPASS THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 2024
Correction: An updated algorithm for an effective choice of continuous glucose monitoring for people with insulin-treated diabetes ENDOCRINE 2024
Deterioration of Vestibular Motion Perception: A Risk Factor for Postural Instability and Falls in Elderly With Type 2 Diabetes DIABETES/METABOLISM RESEARCH AND REVIEWS 2024
Type 2 diabetes in children and adolescents: Challenges for treatment and potential solutions DIABETES RESEARCH AND CLINICAL PRACTICE 2024
Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes DIABETES/METABOLISM RESEARCH AND REVIEWS 2023
Impact of baseline kidney function on the effects of sodium-glucose co-transporter-2 inhibitors on kidney and heart failure outcomes: A systematic review and meta-analysis of randomized controlled trials DIABETES, OBESITY AND METABOLISM 2023
Sex Differences in Cardiovascular Disease and Cardiovascular Risk Estimation in Patients With Type 1 Diabetes THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 2023
Short-term effectiveness of dapagliflozin versus {DPP}-4 inhibitors in elderly patients with type 2 diabetes: a multicentre retrospective study JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2023

Progetti di Ricerca

Gruppi di ricerca - Responsabile

Intervento farmacologico inibente la differenziazione delle cellule mieloidi verso un fenotipo calcificante
Slowly progressive autoimmune diabetes: a clinical model for novel pathways of ß-cell protection
Molecular and pathophysiological heterogeneity of autoimmune diabetes: implications for precision medicine
Synergies anchoring to gravity (SynErg): a novel test to diagnose risk of falls in type 2 diabetes patients

Laboratori di ricerca

Diabetologia e Malattie Metaboliche

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma